SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-034760
Filing Date
2023-12-18
Accepted
2023-12-18 16:35:33
Documents
13
Period of Report
2023-12-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20231207_8k.htm   iXBRL 8-K 30879
  Complete submission text file 0001437749-23-034760.txt   166724

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20231214.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20231214_def.xml EX-101.DEF 11805
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20231214_lab.xml EX-101.LAB 15849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20231214_pre.xml EX-101.PRE 12020
7 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20231207_8k_htm.xml XML 2637
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 231494258
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)